pharma
Boehringer Ingelheim Vetmedica
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
EU HQ
2018 Founded
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Founded
- 2018
- Programs
- 0
- Drugs
- 0
- Patents
- 21
Boehringer Ingelheim Vetmedica pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Boehringer Ingelheim Vetmedica drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.